Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer

Abstract An increasing number of studies have indicated that red blood cell distribution width (RDW) may be a novel biomarker for the diagnosis and prognosis of various malignancies. However, to date, data on the association of RDW with non-small cell lung cancer (NSCLC) are unclear. Our present stu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bin Song, Pengchong Shi, Jianhong Xiao, Yanfang Song, Menglu Zeng, Yingping Cao, Xianjin Zhu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/795e0d9c8d394715bd754ab04baea04f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:795e0d9c8d394715bd754ab04baea04f
record_format dspace
spelling oai:doaj.org-article:795e0d9c8d394715bd754ab04baea04f2021-12-02T18:48:00ZUtility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer10.1038/s41598-020-72585-42045-2322https://doaj.org/article/795e0d9c8d394715bd754ab04baea04f2020-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-72585-4https://doaj.org/toc/2045-2322Abstract An increasing number of studies have indicated that red blood cell distribution width (RDW) may be a novel biomarker for the diagnosis and prognosis of various malignancies. However, to date, data on the association of RDW with non-small cell lung cancer (NSCLC) are unclear. Our present study aimed to explore the value of RDW in NSCLC patients. A total of 338 NSCLC patients, 109 small cell lung cancer (SCLC) patients, and 302 healthy participants were retrospectively analyzed between January 2016 and December 2018. In the present study, we found that RDW was significantly increased in NSCLC patients. Receiver-operating characteristic (ROC) analysis showed that the area under the ROC curve (AUC) of RDW was 0.753 in discriminating NSCLC patients from healthy participants, the optimal cut-off value of RDW was 12.95, and the specificity and sensitivity were 76.33% and 76.16%, respectively. Further analysis found that RDW can enhance the diagnostic performance of Cyfra21-1 and NSE in discriminating NSCLC patients from healthy participants or SCLC patients. Among NSCLC patients, RDW was significantly correlated with TNM stage, T stage, N stage, M stage, and Cyfra21-1, indicating that RDW may be helpful for predicting the prognosis of NSCLC patients. Our findings suggest that RDW can be used as an auxiliary marker for the diagnosis and prognosis of NSCLC.Bin SongPengchong ShiJianhong XiaoYanfang SongMenglu ZengYingping CaoXianjin ZhuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-7 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Bin Song
Pengchong Shi
Jianhong Xiao
Yanfang Song
Menglu Zeng
Yingping Cao
Xianjin Zhu
Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer
description Abstract An increasing number of studies have indicated that red blood cell distribution width (RDW) may be a novel biomarker for the diagnosis and prognosis of various malignancies. However, to date, data on the association of RDW with non-small cell lung cancer (NSCLC) are unclear. Our present study aimed to explore the value of RDW in NSCLC patients. A total of 338 NSCLC patients, 109 small cell lung cancer (SCLC) patients, and 302 healthy participants were retrospectively analyzed between January 2016 and December 2018. In the present study, we found that RDW was significantly increased in NSCLC patients. Receiver-operating characteristic (ROC) analysis showed that the area under the ROC curve (AUC) of RDW was 0.753 in discriminating NSCLC patients from healthy participants, the optimal cut-off value of RDW was 12.95, and the specificity and sensitivity were 76.33% and 76.16%, respectively. Further analysis found that RDW can enhance the diagnostic performance of Cyfra21-1 and NSE in discriminating NSCLC patients from healthy participants or SCLC patients. Among NSCLC patients, RDW was significantly correlated with TNM stage, T stage, N stage, M stage, and Cyfra21-1, indicating that RDW may be helpful for predicting the prognosis of NSCLC patients. Our findings suggest that RDW can be used as an auxiliary marker for the diagnosis and prognosis of NSCLC.
format article
author Bin Song
Pengchong Shi
Jianhong Xiao
Yanfang Song
Menglu Zeng
Yingping Cao
Xianjin Zhu
author_facet Bin Song
Pengchong Shi
Jianhong Xiao
Yanfang Song
Menglu Zeng
Yingping Cao
Xianjin Zhu
author_sort Bin Song
title Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer
title_short Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer
title_full Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer
title_fullStr Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer
title_full_unstemmed Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer
title_sort utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/795e0d9c8d394715bd754ab04baea04f
work_keys_str_mv AT binsong utilityofredcelldistributionwidthasadiagnosticandprognosticmarkerinnonsmallcelllungcancer
AT pengchongshi utilityofredcelldistributionwidthasadiagnosticandprognosticmarkerinnonsmallcelllungcancer
AT jianhongxiao utilityofredcelldistributionwidthasadiagnosticandprognosticmarkerinnonsmallcelllungcancer
AT yanfangsong utilityofredcelldistributionwidthasadiagnosticandprognosticmarkerinnonsmallcelllungcancer
AT mengluzeng utilityofredcelldistributionwidthasadiagnosticandprognosticmarkerinnonsmallcelllungcancer
AT yingpingcao utilityofredcelldistributionwidthasadiagnosticandprognosticmarkerinnonsmallcelllungcancer
AT xianjinzhu utilityofredcelldistributionwidthasadiagnosticandprognosticmarkerinnonsmallcelllungcancer
_version_ 1718377632014270464